Interestingly, their cohort did not display the increases in total monocyte populations in their hospitalized group but displayed decreases in non-classical monocyte percentages and steady levels of classical and intermediate monocyte percentages from total CD45+ cells in participants hospitalized for COVID-19 up to 90 days following admission. This evidence concerns the gene PTPRC and COVID-19.